Results 1 to 10 of about 17,628 (210)
The Use of Adjunct Therapies with Surgery for Gastroenteropancreatic Neuroendocrine Tumors: Indications, Timing, and Outcomes [PDF]
BiomedicinesBackground/Objectives: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare biologically heterogeneous neoplasms but with increasing incidence in recent years. Surgery remains the backbone of treatment; however, long-term recurrence is common
Kathryn Cavallo, Naris Nilubol
doaj +2 more sources
The correlation between the extent of left upper abdominal resections and perioperative outcomes in advanced stage and relapsed ovarian cancer [PDF]
Romanian Journal of Medical Practice, 2020 The aim of this study is to analyze the feasibility and safety of left upper abdominal resections as part of debulking surgery. Case series presentation. Between January 2015 and August 2019, 32 patients were submitted to left upper abdominal resections.
Nicolae BACALBASA +10 more
doaj +1 more source
The role of quaternary cytoreduction in relapsed ovarian cancer – a systematic review [PDF]
Archives of the Balkan Medical Union, 2020 Introduction. Ovarian cancer is characterized by a high capacity of relapse, even in cases in whom cytoreductive surgery with curative intent followed by platinum and taxanes-based chemotherapy were performed.
Nicolae BACALBASA +6 more
doaj +1 more source
Quaternary and beyond cytoreduction: An updated and expanded analysis
Gynecologic Oncology Reports, 2021 Objective: We sought to describe the clinicopathologic features and outcomes of patients undergoing quaternary, quinary, or senary cytoreductive surgery for ovarian cancer. Methods: We retrospectively identified patients with recurrent epithelial ovarian,
Beryl L. Manning-Geist +8 more
doaj +1 more source
Diagnostics, 2023 For women achieving clinical remission after the completion of initial treatment for epithelial ovarian cancer, 80% with advanced-stage disease will develop recurrence.
Faiza Gaba +16 more
doaj +1 more source
Complete repeat cytoreduction under regional anesthesia in a patient with myasthenia gravis: a clinical case [PDF]
Гинекология, 2022 The article summarizes the published data on the prevalence, pathogenesis, features of clinical presentation, and treatment of myasthenia gravis and myasthenic crises.
Sergey A. Chukhnov
doaj +1 more source
Acta Obstetricia et Gynecologica Scandinavica, 2022 Introduction The survival benefits of surgical cytoreduction in ovarian cancer are well‐established. However, the surgical outcome has never been assessed while controlling for the efficacy of chemotherapy.
Nicholas Cardillo +7 more
doaj +1 more source
Clinics and Practice, 2023 Mucinous ovarian cancer occurs sporadically, with a frequency of approximately 3–5% among all subtypes of ovarian cancer. Extreme leukocytosis >40,000 and 50,000 has been described in most solid tumors and is associated with a poor prognosis, although ...
Stojan Latincic +10 more
doaj +1 more source
Results of treatment of cancer patients with peritoneal carcinomatosis
Journal of Education, Health and Sport, 2022 Objective: At present, common forms of cancer of different localization can not be ignored. New approaches to the treatment of metastatic lesions have some success in clinical application.
O. Bondar, A. Rybin, A. Varabina
doaj +1 more source
Pseudomyxoma Peritonei Secondary to Rupture of Intraductal Papillary Neoplasm of Pancreas (IPMN) [PDF]
Journal of Clinical and Diagnostic Research, 2018 Pseudomyxoma peritonei is the intraperitoneal accumulation of a gelatinous ascites secondary to mucinous tumour rupture, more commonly associated with ovarian and appendiceal mucinous tumour.
Saurabh Kumar, Alok Kumar mittal
doaj +1 more source